Search research articles
Contact Us
Filters
Showing results (171-180 of 254) with videos related to
Page
of 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2022
Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation
Abdelrahman H Elsayed, Xueyuan Cao, Amit K Mitra, et al.
Pediatric Blood & Cancer
|
March 12, 2015
Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group
Tamara P Miller, Andrea B Troxel, Yimei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2014
Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531
Alan S Gamis, Todd A Alonzo, Soheil Meshinchi, et al.
Pediatric Blood & Cancer
|
May 7, 2015
Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group
Kelly D Getz, Yimei Li, Todd A Alonzo, et al.
Blood Advances
|
January 23, 2023
SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia
Richard J Marrero, Xueyuan Cao, Huiyun Wu, et al.
Pediatric Blood & Cancer
|
July 13, 2024
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials
Jamie Shoag, Yimei Li, Kelly D Getz, et al.
Blood Advances
|
February 2, 2024
Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia
Oussama Abla, Rhonda E Ries, Tim Triche, et al.
Proteomics. Clinical Applications
|
November 1, 2021
Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA
Anneke D van Dijk, Fieke W Hoff, Yihua Qiu, et al.
Pediatric Blood & Cancer
|
May 12, 2020
Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment
Viviane C Cahen, Yimei Li, Kelly D Getz, et al.
Pediatric Blood & Cancer
|
February 15, 2023
Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group
Karen M Chisholm, Jenny Smith, Amy E Heerema-McKenney, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 254) with videos related to
Sort By:
Page
of 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2022
Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation
Abdelrahman H Elsayed, Xueyuan Cao, Amit K Mitra, et al.
Pediatric Blood & Cancer
|
March 12, 2015
Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group
Tamara P Miller, Andrea B Troxel, Yimei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2014
Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531
Alan S Gamis, Todd A Alonzo, Soheil Meshinchi, et al.
Pediatric Blood & Cancer
|
May 7, 2015
Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group
Kelly D Getz, Yimei Li, Todd A Alonzo, et al.
Blood Advances
|
January 23, 2023
SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia
Richard J Marrero, Xueyuan Cao, Huiyun Wu, et al.
Pediatric Blood & Cancer
|
July 13, 2024
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials
Jamie Shoag, Yimei Li, Kelly D Getz, et al.
Blood Advances
|
February 2, 2024
Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia
Oussama Abla, Rhonda E Ries, Tim Triche, et al.
Proteomics. Clinical Applications
|
November 1, 2021
Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA
Anneke D van Dijk, Fieke W Hoff, Yihua Qiu, et al.
Pediatric Blood & Cancer
|
May 12, 2020
Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment
Viviane C Cahen, Yimei Li, Kelly D Getz, et al.
Pediatric Blood & Cancer
|
February 15, 2023
Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group
Karen M Chisholm, Jenny Smith, Amy E Heerema-McKenney, et al.
Page
of 26